Latest Action
Referred to the Subcommittee on Health.
9/23/2019 • House
Summary
Bolstering Innovative Options to Save Immediately on Medicines Act or the BIOSIM Act
This bill increases Medicare payments for biosimilars for five years. The bill applies to biosimilars for which the average sales price or wholesale acquisition cost is less than that of the reference biological product, as specified.
Introduced in House • 9/20/2019
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Health care costs and insuranceMedicarePrescription drugsProduct development and innovation
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (2)
Party Breakdown
1
Democrats
1
Republicans
0
Independents
Sponsor
R[
Cosponsors (1)
RL
Bill Journey
Originated in the House
Introduced
September 20, 2019
Referred to the Subcommittee on Health.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House9/20/2019